Rogers (ROG) News
NYSE: ROGIndustrialsMajor ChemicalsUSD
147.65-0.474 (-0.32%)
At close: Oct 9, 3:59 PM ET · Delayed 15 min
After hours: 147.41 -0.16%
ROG news summary
We found 1 recent headline mentioning Rogers (ROG): 1 in the past week and 1 in the past 30 days, most often from GlobeNewswire. For price context, ROG is down 0.32% at $147.65. The most recent story, "FDA approves Roche’s Tecentriq in combination with a fluoropyrimidine and oxaliplatin for the adjuvant treatment of a certain type of stage III colon cancer", was published by GlobeNewswire on Oct 9, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology